Oncimmune Holdings plc (LON:ONC – Get Free Report) reached a new 52-week low during trading on Friday . The company traded as low as GBX 10.82 ($0.14) and last traded at GBX 10.82 ($0.14), with a volume of 1243936 shares traded. The stock had previously closed at GBX 11.65 ($0.15).
Oncimmune Stock Performance
The firm has a market capitalization of £8.08 million, a P/E ratio of -363.33 and a beta of 1.09. The stock has a 50-day moving average of GBX 21.80 and a 200 day moving average of GBX 22.88. The company has a debt-to-equity ratio of 806.85, a quick ratio of 0.63 and a current ratio of 3.91.
About Oncimmune
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
Further Reading
- Five stocks we like better than Oncimmune
- What is MarketRank™? How to Use it
- McDonald’s Stock: Balancing Value and Innovation
- What Are Dividend Achievers? An Introduction
- MarketBeat Week in Review – 6/17 – 6/21
- What is Short Interest? How to Use It
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.
